1. Lycium barbarum Polysaccharide Inhibited Hypoxia-Inducible Factor 1 in COPD Patients


    Li-Jun Chen et al, 2020, International Journal of Chronic Obstructive Pulmonary Disease CrossRef
  2. Herb pair Danggui-Honghua: mechanisms underlying blood stasis syndrome by system pharmacology approach
    Shi-Jun Yue et al, 2017, Scientific Reports CrossRef
  3. Rel Family Transcription Factor NFAT5 Upregulates COX2 via HIF-1α Activity in Ishikawa and HEC1a Cells
    Toshiyuki Okumura et al, 2024, International Journal of Molecular Sciences CrossRef
  4. Candesartan ameliorates acute myocardial infarction in rats through inducible nitric oxide synthase, nuclear factor-κB, monocyte chemoattractant protein-1, activator protein-1 and restoration of heat shock protein 72
    XUEFENG LIN et al, 2015, Molecular Medicine Reports CrossRef
  5. Role of the HIF‑1 signaling pathway in chronic obstructive pulmonary disease
    Xiang Fu et al, 2018, Experimental and Therapeutic Medicine CrossRef
  6. Integrating network pharmacological and experimental models to investigate the therapeutic effects of baicalein in glaucoma
    Jiawei Yang et al, 2021, Chinese Medicine CrossRef
  7. Erythropoietin as Potential Neuroprotective and Antiepileptogenic Agent in Epilepsy and Refractory Epilepsy
    Amalia Marelli et al, 2016, Antiepileptic Drug Discovery CrossRef
  8. Use of erythropoietin in ophthalmology: a review
    Sepehr Feizi et al, 2022, Survey of Ophthalmology CrossRef
  9. Tylophorine-based compounds are therapeutic in rheumatoid arthritis by targeting the caprin-1 ribonucleoprotein complex and inhibiting expression of associated c-Myc and HIF-1α
    Yue-Zhi Lee et al, 2020, Pharmacological Research CrossRef
  10. PEGylated Erythropoietin Protects against Brain Injury in the MCAO-Induced Stroke Model by Blocking NF-κB Activation
    Jun Hyung Im et al, 2020, Biomolecules & Therapeutics CrossRef